Home Article Tactile Medical brings MyoSleeve to VA, DOD patients

Tactile Medical brings MyoSleeve to VA, DOD patients

By HME News Staff

Updated 10:23 AM CDT, Tue July 21, 2026

MINNEAPOLIS – Tactile Medical has paid ElastiMed $3 million for the exclusive rights to distribute MyoSleeve, a wearable non-pneumatic compression device for the lower leg, to patients of the Department of Veterans Affairs and Department of Defense in the United States. MyoSleeve expands Tactile Medical’s portfolio by providing a new treatment option for appropriate patients in earlier stages of chronic swelling who may not yet require more intensive compression therapy, the company says. “Our agreement with ElastiMed adds a differentiated, wearable compression option to Tactile Medical’s portfolio and reflects our strategy of expanding access to patient-focused solutions across the continuum of chronic swelling care,” said Sheri Dodd, CEO of Tactile Medical. “For the right patient, MyoSleeve offers unobtrusive compression therapy that fits into daily life, giving patients the freedom to stay mobile while engaged in their own care.” Tactile Medical has also committed to certain minimum purchase obligations and marketing and sales promotion as it supports ElastiMed’s growth. The company plans to leverage its established sales organization, billing and payment expertise, and patient support infrastructure to drive MyoSleeve commercialization and support ongoing market access initiatives. It believes MyoSleeve may also be appropriate as a complementary treatment to a traditional pneumatic compression device and for patients who struggle with conservative therapy, or those with mobility-limiting cases.